Model N Fall 2022 Product Offering Addresses Dynamic Market Needs
Revenue optimization and compliance leader delivers market-ready tools to support shifting priorities for life sciences and high-tech companies
“Today’s life sciences and high-tech innovators are feeling the pressure of an ever-changing market economy to act quickly while maintaining compliance. To empower our customers to keep thriving and making business critical decisions, Model N’s newest product enhancements were built to power our customers’ innovation, profitability, and business growth,” said
Enhancing Profitability for Life Sciences
The latest life sciences enhancements will help pharmaceutical and medtech manufacturers achieve compliance and more quickly meet their strategic objectives. Model N’s customers will be able to better forecast the revenue and pricing impacts of a drug falling off patent, ensure they are able to receive and process the latest payer, prescriber, and government data standards, and more accurately calculate Medicaid rebates. Combined with the increased ability to control contract pricing communication with internal and external parties, companies can be confident the right products are delivered to the right providers at the right prices. Additionally, customers will have critical performance metrics at their fingertips—showcasing contracted sales and overall savings trends, chargebacks and rebates, and fee savings.
Proactive Market Response for High-Tech
An important benefit for high-tech companies is a
“As data standards and market dynamics evolve, our customers expect more out of technology partners to help them stand out and power innovation,” said
To learn more about the Model N Fall 2022 product release, visit www.modeln.com.
About
Our integrated cloud solution is proven to automate pricing, incentive and contract decisions to scale business profitably and grow revenue.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005408/en/
Media Contacts:
Public Relations
BLASTmedia
press@modeln.com
Investor Relations
Investorrelations@modeln.com
Source: